Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials

Lancet

Volumn 361, Issue 9351, 2003, Pages 13-20

  Keeley, Ellen C ^a   Boura, Judith A ^b   Grines, Cindy L ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DUTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; FATALITY; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART ASSIST DEVICE; HEART DEATH; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; STROKE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0037417523     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12113-7     Document Type: Article

References (41)

1. Davies M.J., Woolf N., Robertson W.B. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br Heart J. 38:1976;659-664.
2. Rentrop K.P., Blanke H., Karsch K.R., et al. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol. 2:1979;354-363.
3. Selection of reperfusion therapy for individual patients with evolving myocardial infarction. Eur Heart J. 18:1997;1371-1381.
4. O'Neill W., Timmis G.C., Bourdillon P.D., et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med. 314:1986;812-818.
5. Michels K.B., Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation. 91:1995;476-485.
6. Weaver W.D., Simes R.J., Betriu A., et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 278:1997;2093-2098.
7. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 341:1999;625-634.
8. Zijlstra F., de Boer M.J., Hoorntje J.C., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 328:1993;680-684.
9. Ribeiro E.E., Silva L.A., Carneiro R., et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol. 22:1993;376-380.
10. Grinfeld L., Berrocal D., Belardi J., et al. Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP): a randomized trial in a community hospital in Argentina. J Am Coll Cardiol. 27:(suppl.):1996;A222.
11. Zijlstra F., Beukema W.P., van't Hof A.W., et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol. 29:1997;908-912.
12. Akhras F., Abu Ousa A., Swann G., et al. Primary coronary angioplasty or intravenous thrombolysis for patients with acute myocardial infarction? Acute and late follow-up results in a new cardiac unit. J Am Coll Cardiol. 29:(suppl):1997;A235-236.
13. Widimsky P., Groch L., Zelizko M., et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory: The PRAGUE study. Eur Heart J. 21:2000;823-831.
14. de Boer M.J., Ottervanger J.P., van't Hof A.W., Hoorntje J.C., Suryapranata H., Zijlstra F. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 39:2002;1723-1728.
15. Widimsky P. PRAGUE-2 trial. Conference of the European Society of Cardiology, Sept 1, 2002; Berlin, Germany.
16. DeWood MA. Direct PTCA vs intravenous t-PA in acute myocardial infarction: Results from a prospective randomized trial. Thrombolysis and Interventional Therapy in Acute Myocardial Infarction Symposium VI. Washington: George Washington University, 1990.
17. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
18. Gibbons R.J., Holmes D.R., Reeder G.S., et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 328:1993;685-691.
19. Ribichini F., Steffenino G., Dellavalle A., et al. Primary angioplasty versus thrombolysis in inferior acute myocardial infarction with anterior ST-segment depression, a single-center randomized trial. J Am Coll Cardiol. 27:(suppl):1996;A221.
20. Ribichini F., Steffenino G., Dellavalle A., et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. J Am Coll Cardiol. 32:1998;1687-1694.
21. Garcia E., Elizaga J., Soriano J., et al. Primary angioplasty versus thrombolysis with tPA in anterior myocardial infarction: results from a single trial. J Am Coll Cardiol. 29:(suppl):1997;A389.
22. Garcia E., Elizaga J., Perez-Castellano N., et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol. 33:1999;605-611.
23. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 336:1997;1621-1628.
24. Le May M.R., Labinaz M., Davies R.F., et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol. 37:2001;985-991.
25. Bonnefoy E., Lapostolle F., Leizorovicz A., et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet. 360:2002;825-829.
26. Schomig A., Kastrati A., Dirschinger J., et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 343:2000;385-391.
27. Vermeer F., Oude Ophuis A.J., van der Berg E.J., et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart. 82:1999;426-431.
28. Andersen H. DANAMI-2: The Danish trial in acute coronary angioplasty in acute myocardial infarction. Clin Cardiol. 25:2002;301.
29. Kastrati A., Mehilli J., Dirschinger J., et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet. 359:2002;920-925.
30. Aversano T., Aversano L.T., Passamani E., et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 287:2002;1943-1951.
31. Grines C.L., Westerhausen D.R., Grines L.L., et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. J Am Coll Cardiol. 39:2002;1713-1719.
32. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
33. Zijlstra F., Hoorntje J.C., de Boer M.J., et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 341:1999;1413-1419.
34. Simes J, Patel A, Zijlstra F, Weaver WD, Granger C, Grines CL. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six month follow-up and analysis of individual patient data from randomized trials. Am Heart J (in press).
35. Zijlstra F., de Boer M.J., Ottervanger J.P., et al. Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in outcome during a mean follow-up of 18 months. Coron Artery Dis. 5:1994;707-712.
36. Zijlstra F., Patel A., Jones M., et al. Clinical characteristics and outcome of patients with early (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J. 23:2002;550-557.
37. Hochman J.S., Sleeper L.A., White H.D., et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 285:2001;190-192.
38. Nunn C.M., O'Neill W.W., Rothbaum D., et al. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol. 33:1999;640-646.
39. Hasdai D., Behar S., Wallentin L., et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. Eur Heart J. 23:2002;1190-1201.
40. Magid D.J., Calonge B.N., Rumsfeld J.S., et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA. 284:2000;3131-3138.
41. Canto J.G., Every N.R., Magid D.J., et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med. 342:2000;1573-1580.